https://orcid.org/0000-0002-1784-3827
References
- Sap JBI, Meyer CF, Straathof NJW, et al. Late-stage difluoromethylation: concepts, developments and perspective. Chem Soc Rev. 2021;50(14):8214–8247. doi:10.1039/D1CS00360G
- Zafrani Y, Yeffet D, Sod-Moriah G, et al. Difluoromethyl bioisostere: examining the “lipophilic hydrogen bond donor” concept. J Med Chem. 2017;60(2):797–804. doi:10.1021/acs.jmedchem.6b01691
- Tinworth CP, Young RJ. Facts, patterns, and principles in drug discovery: appraising the rule of 5 with measured physicochemical data. J Med Chem. 2020;63(18):10091–10108. doi:10.1021/acs.jmedchem.9b01596
- Sessler CD, Rahm M, Becker S, Goldberg JM, Wang F, Lippard SJ. CF2H, a hydrogen bond donor. J Am Chem Soc. 2017;139(27):9325–9332. doi:10.1021/jacs.7b04457
- Zafrani Y, Saphier S, Gershonov E. Utilizing the CF2H moiety as a H-bond-donating group in drug discovery. Future Med Chem. 2020;12(5):361–365. doi:10.4155/fmc-2019-0309
- Abraham MH, Abraham RJ, Acree WEJ, Aliev AE, Leo AJ, Whaley WL. An NMR method for the quantitative assessment of intramolecular hydrogen bonding; application to physicochemical, environmental, and biochemical properties. J Org Chem. 2014;79(22):11075–11083. doi:10.1021/jo502080p
- Zafrani Y, Sod-Moriah G, Yeffet D, et al. CF2H, a functional group-dependent hydrogen-bond donor: is it a more or less lipophilic bioisostere of OH, SH, and CH3? J Med Chem. 2019;62(11):5628–5637. doi:10.1021/acs.jmedchem.9b00604
- Böttcher T, Bassil BS, Zhechkov L, Röschenthaler G-V. Phosphorus(V) complexes with acyclic monoaminocarbene ligands via oxidative addition. Inorg Chem. 2013;52(10):5651–5653. doi:10.1021/ic400756z
- Zafrani Y, Amir D, Yehezkel L, et al. Chemoselective N-difluoromethylation of functionalized tertiary amines. J Org Chem. 2016;81:9180–9187. doi:10.1021/acs.joc.6b01728
- Graton J, Compain G, Besseau F, et al. Influence of alcohol β-fluorination on hydrogen-bond acidity of conformationally flexible substrates. Chem A Eur J. 2017;23(12):2811–2819. doi:10.1002/chem.201604940
- Giuffredi GT, Gouverneur V, Bernet B. Intramolecular OH⋯FC hydrogen bonding in fluorinated carbohydrates: CHF is a better hydrogen bond acceptor than CF2. Angew Chemie Int Ed. 2013;52(40):10524–10528. doi:10.1002/anie.201303766
- Zafrani Y, Parvari G, Amir D, et al. Modulation of the H-bond basicity of functional groups by α-fluorine-containing functions and its implications for lipophilicity and bioisosterism. J Med Chem. 2021;64(8):4516–4531. doi:10.1021/acs.jmedchem.0c01868
- Columbus I, Ghindes-Azaria L, Herzog IM, et al. Species-specific lipophilicities of fluorinated diketones in complex equilibria systems and their potential as multifaceted reversible covalent warheads. Commun Chem. 2023;6(1):197. doi:10.1038/s42004-023-01004-2
- Caron G, Kihlberg J, Ermondi G. Intramolecular hydrogen bonding: an opportunity for improved design in medicinal chemistry. Med Res Rev. 2019;39(5):1707–1729. doi:10.1002/med.21562
- Jones CR, Baruah PK, Thompson AL, Scheiner S, Smith MD. Can a C–H⋯O interaction be a determinant of conformation? J Am Chem Soc. 2012;134(29):12064–12071. doi:10.1021/ja301318a
- Waring MJ. Lipophilicity in drug discovery. Expert Opin Drug Discov. 2010;5(3):235–248. doi:10.1517/17460441003605098
- Huchet QA, Kuhn B, Wagner B, et al. On the polarity of partially fluorinated methyl groups. J Fluor Chem. 2013;152:119–128. doi:10.1016/j.jfluchem.2013.02.023
- Müller K. Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups. Chimia (Aarau). 2014;68(6):356. doi:10.2533/chimia.2014.356
- Columbus I, Ghindes-Azaria L, Chen R, et al. Studying lipophilicity trends of phosphorus compounds by 31P-NMR spectroscopy: a powerful tool for the design of P-containing drugs. J Med Chem. 2022;65(12):8511–8524. doi:10.1021/acs.jmedchem.2c00658
- Saphier S, Katalan S, Yacov G, et al. Placing CF 2 in the center: major physicochemical changes upon a minor structural alteration in gem-difunctional compounds. Chem A Eur J. 2023;29(7):e202202939. doi:10.1002/chem.202202939